Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FUSION ANTIBODIES PLC | 40,000 | net | 31 Oct 2022 | tx 2+40,000 |
| Fusion Antibodies PLC Ordinary Shares | 15,593 | net | 15 Jan 2018 | tx 1+15,593 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Oct 2022 | PURCHASE | FUSION ANTIBODIES PLC | 10,000 | 0.42 GBP | first after silence |
| 02 Jul 2019 | PURCHASE | FUSION ANTIBODIES PLC | 30,000 | 0.69 GBP | first after silence |
| 15 Jan 2018 | PURCHASE | Fusion Antibodies PLC Ordinary Shares | 15,593 | 1.60 GBP |
2 purchases reported after at least 12 months of silence — most recent on 31 Oct 2022.